Editas Medicine Inc
NASDAQ:EDIT
Balance Sheet
Balance Sheet Decomposition
Editas Medicine Inc
Current Assets | 340.8m |
Cash & Short-Term Investments | 323.1m |
Receivables | 10.2m |
Other Current Assets | 7.5m |
Non-Current Assets | 158.3m |
Long-Term Investments | 104m |
PP&E | 45.7m |
Other Non-Current Assets | 8.6m |
Current Liabilities | 63.2m |
Accounts Payable | 8.3m |
Accrued Liabilities | 46.7m |
Other Current Liabilities | 8.2m |
Non-Current Liabilities | 86.8m |
Other Non-Current Liabilities | 86.8m |
Balance Sheet
Editas Medicine Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
11
|
143
|
185
|
147
|
135
|
238
|
140
|
204
|
142
|
124
|
|
Cash Equivalents |
11
|
143
|
185
|
147
|
135
|
238
|
140
|
204
|
142
|
124
|
|
Short-Term Investments |
0
|
0
|
0
|
183
|
234
|
219
|
262
|
296
|
203
|
199
|
|
Total Receivables |
0
|
1
|
0
|
1
|
0
|
0
|
6
|
0
|
5
|
10
|
|
Accounts Receivables |
0
|
1
|
0
|
1
|
0
|
0
|
6
|
0
|
5
|
10
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
0
|
1
|
2
|
2
|
6
|
6
|
11
|
7
|
7
|
8
|
|
Total Current Assets |
11
|
145
|
187
|
332
|
375
|
464
|
419
|
507
|
357
|
341
|
|
PP&E Net |
1
|
2
|
40
|
39
|
40
|
40
|
39
|
43
|
59
|
46
|
|
PP&E Gross |
1
|
2
|
40
|
39
|
40
|
40
|
39
|
43
|
59
|
46
|
|
Accumulated Depreciation |
0
|
1
|
2
|
4
|
7
|
7
|
11
|
16
|
22
|
26
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
110
|
120
|
93
|
104
|
|
Other Long-Term Assets |
0
|
2
|
2
|
2
|
5
|
5
|
5
|
7
|
5
|
9
|
|
Total Assets |
12
N/A
|
149
+1 125%
|
229
+53%
|
373
+63%
|
420
+13%
|
509
+21%
|
573
+13%
|
678
+18%
|
514
-24%
|
499
-3%
|
|
Liabilities | |||||||||||
Accounts Payable |
3
|
1
|
5
|
4
|
5
|
6
|
6
|
5
|
10
|
8
|
|
Accrued Liabilities |
2
|
6
|
17
|
11
|
13
|
28
|
31
|
31
|
42
|
47
|
|
Short-Term Debt |
0
|
0
|
10
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
2
|
0
|
1
|
14
|
18
|
26
|
21
|
11
|
8
|
8
|
|
Total Current Liabilities |
6
|
7
|
33
|
37
|
36
|
60
|
58
|
47
|
60
|
63
|
|
Long-Term Debt |
0
|
0
|
35
|
33
|
32
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
26
|
26
|
95
|
116
|
187
|
121
|
77
|
94
|
87
|
|
Total Liabilities |
7
N/A
|
33
+387%
|
95
+190%
|
165
+75%
|
184
+12%
|
246
+34%
|
179
-27%
|
124
-31%
|
154
+24%
|
150
-2%
|
|
Equity | |||||||||||
Common Stock |
21
|
200
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
15
|
88
|
186
|
306
|
416
|
549
|
665
|
858
|
1 078
|
1 231
|
|
Additional Paid In Capital |
0
|
5
|
320
|
514
|
653
|
812
|
1 059
|
1 412
|
1 442
|
1 580
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
0
|
|
Total Equity |
6
N/A
|
117
+2 024%
|
135
+15%
|
208
+55%
|
236
+14%
|
262
+11%
|
394
+50%
|
554
+41%
|
361
-35%
|
349
-3%
|
|
Total Liabilities & Equity |
12
N/A
|
149
+1 125%
|
229
+53%
|
373
+63%
|
420
+13%
|
509
+21%
|
573
+13%
|
678
+18%
|
514
-24%
|
499
-3%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
36
|
36
|
36
|
45
|
49
|
55
|
63
|
68
|
69
|
82
|